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Abstract
Aims The aim of this study was to investigate whether leisure-time physical activity (LTPA) is associated with the develop-
ment of severe diabetic retinopathy in individuals with type 1 diabetes.
Methods Prospective observational analysis as part of the Finnish diabetic nephropathy (FinnDiane) Study with a mean 
follow-up time of 10.7 years was performed. A total of 1612 individuals with type 1 diabetes were recruited, and LTPA was 
assessed at baseline using a validated self-report questionnaire. Severe diabetic retinopathy was defined as the initiation of 
laser treatment due to severe nonproliferative, proliferative retinopathy or diabetic maculopathy (identified from the Care 
Register for Health Care).
Results A total of 261 patients received laser treatment during the follow-up. Higher frequency of LTPA was associated with 
a lower incidence of severe diabetic retinopathy (p = 0.024), a finding that remained significant after adjustment for gender, 
duration, age at onset of diabetes, kidney function, BMI, triglycerides and systolic blood pressure. However, when  HbA1c 
and smoking were added to the Cox regression model the association was no more significant.
Conclusions Frequent LTPA is associated with a lower incidence of severe diabetic retinopathy during the follow-up. The 
total amount or the other components of LTPA (intensity or duration of a single session) were not associated with severe 
diabetic retinopathy.
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Introduction
Physical activity has been shown to be beneficial for indi-
viduals with type 1 diabetes and is associated with reduced 
risk of cardiovascular disease (CVD) events and premature 
mortality [1–6]. However, studies regarding physical activity 
and microvascular complications are limited in this patient 
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group. This is particularly true for the relationship between 
physical activity and risk of diabetic retinopathy, and so far, 
no clear relationships have been found [5–7].
Among the studies that have addressed this issue, the 
Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity 
and Mortality Study made the first large attempt, but that 
study did not find any statistically significant associations 
between physical activity and diabetic retinopathy [5, 6]. 
However, the landmark Wisconsin Epidemiologic Study 
of Diabetic Retinopathy (WESDR) showed that participa-
tion in high school team sports was associated with a lower 
incidence of diabetic retinopathy, but only in a subgroup 
of women diagnosed with diabetes under the age of 14 [7].
In our previous study, we showed that a higher inten-
sity of physical activity is associated with a lower risk of 
progression of diabetic nephropathy during the follow-up 
[8]. Notably, diabetic nephropathy and retinopathy repre-
sent common soil and share the same risk factors. In line 
with this, we previously showed that low-intensity LTPA 
was associated with proliferative retinopathy in a cross-
sectional setting [9]. However, whether physical activity 
is beneficial also in individuals with type 1 diabetes with 
respect to diabetic retinopathy in a longitudinal setting is not 
clear. Therefore, the aim of this study was to assess whether 
baseline leisure-time physical activity (LTPA) and its com-
ponents (intensity, duration and frequency) are associated 
with the development of severe diabetic retinopathy during 
the follow-up in individuals with type 1 diabetes.
Methods
This prospective observational study is part of the ongo-
ing Finnish Diabetic Nephropathy Study that has previ-
ously been described in detail [10]. The FinnDiane Study 
has recruited and thoroughly characterized more than 5000 
individuals with type 1 diabetes at 92 centres throughout 
Finland. Included in the present study are those 1612 indi-
viduals with type 1 diabetes that had both LTPA and data on 
severe diabetic retinopathy available. Notably, patients that 
were blind (n = 1), had previously received laser treatment 
(n = 956) and had end-stage renal disease (n = 14) or unclear 
renal status at baseline were excluded (n = 79). At baseline, 
41 patients had a major CVD event (myocardial infarction, 
coronary procedure or stroke). Type 1 diabetes was defined 
as a diagnosis of diabetes before the age of 40 years and 
permanent insulin treatment initiated within 1 year of the 
diagnosis. The study protocol was approved by the Ethical 
Committee of the Helsinki and Uusimaa Hospital District 
as well as by the local ethics committees at the participat-
ing centres and conducted according to the Declaration of 
Helsinki. All patients gave their written informed consent.
The primary study end point was severe diabetic retin-
opathy, defined as the initiation of laser treatment due to 
severe nonproliferative retinopathy, proliferative retinopathy 
or diabetic maculopathy identified from the Care Register 
for Health Care (HILMO).
Renal function (eGFR) was estimated using the CKD-
EPI equation [11]. Renal status was categorized based on 
the urinary albumin excretion rate (AER) in either a timed 
overnight or 24-h urine collection in at least two out of three 
consecutive measurements as follows: normal AER, < 20 μg/
min or < 30 mg/24 h (n = 1396); microalbuminuria, ≥ 20 
and < 200 μg/min or ≥ 30 and < 300 mg/24 h (n = 154); or 
macroalbuminuria, ≥ 200 μg/min or ≥ 300 mg/24 h (n = 62). 
End-stage renal disease (ESRD; n = 14) was defined as ongo-
ing dialysis or having received a previous kidney transplant. 
Blood pressure was measured after a 10-min rest twice in the 
sitting position with 2-min intervals, and the average of these 
two measurements was used in the analysis. Anthropomet-
ric data (weight, height, and waist and hip circumference) 
were recorded by a trained nurse. Fasting blood samples 
were drawn for the determination of  HbA1c, lipid profile and 
serum creatinine. Smoking was assessed by a standardized 
questionnaire.
LTPA at baseline was assessed by a validated LTPA 
questionnaire. The questionnaire is based on the Kuopio 
Ischemic Heart Disease Risk Factor Study (KIHD) ques-
tionnaire that had been converted from the Minnesota LTPA 
questionnaire to a Finnish setting [13, 14]. The Minnesota 
LTPA questionnaire was validated by doubly labelled water 
and the KIHD LTPA questionnaire in turn by  VO2 max 
[12–14]. The LTPA questionnaire contains information on 
the general type, frequency, intensity and duration of the 
patient’s physical activity recalled from the past 12 months. 
The total amount of LTPA is presented as METh/week, 
and patients were categorized as physically inactive (< 10 
METh/week), moderately active (10–40 METh/week) and 
active (> 40 METh/week). In addition, LTPA intensity, sin-
gle session duration and LTPA frequency were recorded. 
Patients were classified regarding these LTPA components 
as follows: intensity—low (no self-reported subjective 
shortness of breath and no sweating), moderate (a moderate 
degree of self-reported subjective shortness of breath and 
sweating) and high (a high degree of subjective shortness of 
breath and sweating); frequency—low (less than 1 session/
week), moderate (1–2 sessions/week) and high (more than 2 
sessions/week); duration—low (≤ 30 min/session), moderate 
(31–60 min/session) and high (> 60 min/session).
Statistical analysis
The statistical analyses were conducted using the SPSS 
Statistics Software (version 22.2, IBM, Armonk, NY, 
USA). Comparisons between the groups were made using 
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ANOVA for normally distributed variables and with the 
Kruskal–Wallis test for non-normally distributed variables. 
The chi-square test was used for categorical variables. Cat-
egorical variables are given as percentages. Normally dis-
tributed continuous variables are presented as mean ± SD, 
and those not normally distributed as median with interquar-
tile range.
The cumulative incidence rates of severe diabetic retin-
opathy were assessed by the Kaplan–Meier method, and 
the logrank test was used to test the differences between 
groups. In the Kaplan–Meier analyses, the comparisons 
between the different levels of LTPA (low, moderate and 
high) were assessed by trend test when appropriate. The fol-
low-up started from the baseline visit, and the person-years 
at risk were calculated until the first severe diabetic retin-
opathy event, death or the end of year 2015. The associa-
tion between different LTPA components and severe diabetic 
retinopathy was analysed using Cox proportional univariable 
and multivariable hazard regressions. A p value less than 
0.05 was considered statistically significant.
Results
The total number of individuals studied was 1612, and the 
mean follow-up time was 10.7 ± 4.6 years. Of the whole pop-
ulation, 44.7% were men, mean age was 37.0 ± 11.9 years, 
mean duration of diabetes 18.9 ± 11.7 years, mean sys-
tolic blood pressure (SBP) 131 ± 16 mmHg, mean BMI 
25.1 ± 3.6, mean  HbA1c 66.3 ± 14.9 mmol/mol (8.2 ± 1.4%), 
median LTPA 17.7 (8.3–33.5) METh/week, and 41.5% of 
the studied individuals were previous or current smokers.
The baseline clinical characteristics regarding total LTPA 
are shown in Table 1. Physically inactive patients were more 
often men and had a history of smoking. They had also 
worse glycaemic control and lipid profile and were more 
often obese. Table 2 presents the baseline clinical character-
istics regarding the development of severe diabetic retinopa-
thy. At baseline, the patients that developed severe retinopa-
thy were younger and had higher blood pressure and BMI, 
worse lipid profile, higher  HbA1c, more often a history of 
smoking and more frequent use of antihypertensive drugs.
During the follow-up, a total of 261 of the patients devel-
oped severe diabetic retinopathy. The 10-year cumulative 
incidence rates for all LTPA components are shown in 
Table 3. In these Kaplan–Meier analyses, only frequency of 
physical activity was associated with a lower incidence of 
severe diabetic retinopathy during the follow-up.
The multivariable analyses regarding total LTPA, the 
LTPA components and the development of severe diabetic 
retinopathy are shown in Table 4. Model 1 is a univariable 
Cox regression model for the LTPA components and dia-
betic retinopathy. In the first model, the LTPA frequency 
was associated with a lower incidence of severe diabetic 
Table 1  Baseline clinical 
characteristics stratified by 
LTPA
Data are mean ± SD, median (IQR) or percentages
p values denote comparisons over three groups
WHR Waist-to-hip ratio; AHT antihypertensive medication; SBP systolic blood pressure; DBP diastolic 
blood pressure; LTPA leisure-time physical activity
Physically inactive Moderately active Active p value
N 482 833 297
Sex (men %) 50.2 41.1 46.1 0.005
Age (years) 36.9 ± 12.3 37.2 ± 11.7 36.7 ± 11.8 0.755
Duration of diabetes (years) 18.6 ± 11.8 19.1 ± 11.6 19.1 ± 11.7 0.722
BMI (kg/m2) 25.4 ± 3.8 25.1 ± 3.5 25.0 ± 3.1 0.145
WHR men 0.91 ± 0.07 0.90 ± 0.07 0.89 ± 0.06 0.013
WHR women 0.83 ± 0.06 0.81 ± 0.06 0.81 ± 0.07 0.021
SBP (mmHg) 132 ± 16 131 ± 16 131 ± 16 0.766
DBP (mmHg) 79 ± 10 79 ± 9 78 ± 9 0.850
HbA1c (%) 8.4 ± 1.4 8.1 ± 1.3 8.2 ± 1.4 0.001
HbA1c (mmol/mol) 68 ± 15 65 ± 15 66 ± 16 0.001
Total cholesterol (mmol/l) 4.80 ± 0.83 4.78 ± 0.86 4.75 ± 0.89 0.766
HDL cholesterol (mmol/l) 1.42 ± 0.40 1.49 ± 0.39 1.47 ± 0.42 0.014
LDL cholesterol (mmol/l) 2.86 ± 0.76 2.83 ± 0.78 2.78 ± 0.79 0.463
Triglycerides (mmol/l) 1.02 (0.76–1.46) 0.92 (0.71–1.26) 0.93 (0.71–1.32) 0.001
AHT (%) 25.3 20.8 22.6 0.173
Beta-blockers (%) 6.3 5.0 4.7 0.529
Ever-smokers (%) 51.4 39.7 37.8 < 0.001
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retinopathy during the follow-up. Next, we added the static 
risk factors to model 1: gender, duration, age at onset of 
diabetes and eGFR. After adjustment for these static con-
founders, LTPA frequency was still associated with severe 
diabetic retinopathy. Next, we added the dynamic risk fac-
tors triglycerides, systolic blood pressure, BMI and  HbA1c 
to model 3, and the association between LTPA frequency 
and severe diabetic retinopathy was no more significant. The 
final Cox regression model included the previous confound-
ers and history of smoking. There was no association with 
severe diabetic retinopathy in this model. Notably,  HbA1c 
and history of smoking showed a strong association with 
the development of severe diabetic retinopathy. Interestingly, 
after adjustment for the static risk factors (model 2) as well 
as BMI, triglycerides and systolic blood pressure, the fre-
quency of physical activity was still associated with severe 
diabetic retinopathy (p = 0.045). However, the association 
was no more significant after adding either history of smok-
ing or  HbA1c to the model. The total amount of LTPA or 
the other components (intensity and duration) showed no 
association either in univariable or in multivariable models.
We also performed the same analyses separately for indi-
viduals with normal AER. There was no association with 
LTPA or its components with severe diabetic retinopathy in 
this subgroup (N = 1396). However, the number of patients 
with severe diabetic retinopathy in this particular group 
was small (N = 190), and statistical power rather low. We 
also performed the same analyses in patients (N = 179) with 
normal AER, HbA1c < 8%, SBP < 135, BMI < 25 and with 
no history of smoking. In this subgroup, neither LTPA fre-
quency nor the total amount of LTPA was associated with 
the development of severe diabetic retinopathy. This might 
be due to reduced power. Also, when the analyses were con-
ducted in men and women separately, no associations were 
found.
Table 2  Baseline clinical characteristics regarding development of 
severe diabetic retinopathy
Data are mean ± SD, median (IQR) or percentages
WHR Waist-to-hip ratio; AHT antihypertensive medication; SBP sys-
tolic blood pressure; DBP diastolic blood pressure; LTPA leisure-time 
physical activity
No retinopathy Retinopathy p value
N 1351 261
Sex (men %) 44.3 48.1 0.261
Age (years) 37.3 ± 11.9 35.6 ± 11.7 0.036
Duration of diabetes 
(years)
18.7 ± 12.0 19.8 ± 9.8 0.160
BMI (kg/m2) 25.1 ± 3.6 25.5 ± 3.5 0.048
WHR men 0.90 ± 0.07 0.90 ± 0.07 0.755
WHR women 0.82 ± 0.06 0.82 ± 0.06 0.211
SBP (mmHg) 131 ± 16 134 ± 17 0.003
DBP (mmHg) 78 ± 9 80 ± 10 0.001
HbA1c (%) 8.0 ± 1.2 9.1 ± 1.6 < 0.001
HbA1c (mmol/mol) 64 ± 14 76 ± 17 < 0.001
Total cholesterol 
(mmol/l)
4.75 ± 0.84 4.94 ± 0.89 0.001
HDL cholesterol 
(mmol/l)
1.49 ± 0.40 1.37 ± 0.40 < 0.001
LDL cholesterol 
(mmol/l)
2.80 ± 0.77 2.98 ± 0.79 0.001
Triglycerides 
(mmol/l)
0.92 (0.71–1.28) 1.04 (0.82–1.53) < 0.001
AHT (%) 20.8 31.3 < 0.001
Beta-blockers (%) 5.3 5.4 0.944
Ever-smokers (%) 41.5 49.2 0.023
eGFR 99 ± 21 99 ± 21 0.941
Table 3  The 10-year cumulative incidence rates and 95% CI for the development of severe diabetic retinopathy by LTPA as well as by LTPA 
intensity, duration and frequency
LTPA leisure-time physical activity
*LTPA: Low < 10 METh/week; moderate 10–40 METh/week and high > 40 METh/week; intensity: low (no self-reported subjective shortness of 
breath and no sweating); moderate (a moderate degree of self-reported subjective shortness of breath and sweating); and high (a high degree of 
subjective shortness of breath and sweating). Duration: low ≤ 30, moderate 31–60 and high > 60 min/session. Frequency: low < 1, moderate 1–2 
and high > 2 sessions/week
LTPA Intensity Frequency Duration
Low* 15.6% (12.6,18.5) N = 482, 86 
events
13.3% (9.9,16.7) N = 331,52 
events
15.8% (12.3, 19.2) N = 328, 62 
events
14.1% (9.4,18.5) N = 187, 30 
events
Moderate* 13.7% (11.2,15.6) N = 833, 132 
events
14.1% (11.9,16.3) N = 857,137 
events
15.8% (12.6, 18.9) N = 420, 74 
events
14.0% (11.8,16.2) N = 820, 128 
events
High* 13.1% (9.4,17.1) N = 297, 43 
events
15.0% (11.8,18.1) N = 388, 67 
events
12.7% (10.6,14.7) N = 847,123 
events
14.7% (11.8,17.5) N = 491, 84 
events
p value P = 0.12 p = 0.64 p = 0.024 p = 0.84
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Discussion
In this prospective observational study, we show that fre-
quency of LTPA is associated with a lower incidence of 
severe diabetic retinopathy in type 1 diabetes. The finding 
was unaffected by adjustment for gender, renal function, age 
at onset and duration of diabetes, BMI, systolic blood pres-
sure or triglycerides. However, after adjustment for  HbA1c or 
history of smoking the association was no more significant. 
Neither total LTPA, nor single session duration nor intensity 
was associated with severe diabetic retinopathy during the 
follow-up.
To our knowledge, this is the first time an association 
between physical activity and severe diabetic retinopathy 
has been shown in an entire cohort of individuals with type 1 
diabetes, even after adjustment for a number of confounders. 
So far, the only prospective studies that have assessed the 
relationship between physical activity and diabetic retinopa-
thy are the Pittsburgh and the WESDR studies [5–7]. The 
Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity 
and Mortality Study reported a trend towards a lower risk of 
severe diabetic retinopathy in individuals who participated 
in team sports. The findings were, however, not statistically 
significant. A further 5-year follow-up of the same cohort 
revealed similar findings. In men, physical activity during 
high school was associated with less signs of retinopathy, 
but adjustment for duration of diabetes eliminated the rela-
tionship. [5, 6] Importantly, these earlier studies showed no 
negative effect of physical activity on the development of 
severe diabetic retinopathy. The WESDR showed in women 
with diabetes diagnosis before the age of 14 years that par-
ticipation in team sports during high school or college was 
associated with a lower incidence of proliferative diabetic 
retinopathy. This relationship remained significant when 
adjusted for age and duration of diabetes. However, in men, 
or in other patients in the WESDR cohort no such associa-
tions were found. Our study extends these previous results 
to both genders and suggests that there is an association 
between physical activity and lower incidence of severe dia-
betic retinopathy.
In our previous study on physical activity and diabetic 
nephropathy, the intensity seemed to be the most important 
component of LTPA for the progression of kidney disease 
[8]. Since diabetic nephropathy is closely linked to diabetic 
retinopathy, we assumed that the intensity would also be 
associated with the risk of severe diabetic retinopathy. Such 
a view was supported by our previous cross-sectional data, 
showing that the intensity was indeed associated with dia-
betic retinopathy [9]. To our surprise, only the frequency of 
LTPA showed an association in this longitudinal data set. In 
fact, in the higher-intensity groups, the cumulative incidence 
of severe diabetic retinopathy was even higher, although not 
significant. The reason for this is unknown, but it can be 
assumed that a more precise retinopathy status is required 
to be able to assess the relationship, potential drawbacks 
or benefits between intensive physical activity and diabetic 
retinopathy. The current ADA recommendations for dia-
betes and physical activity state that: “Vigorous aerobic or 
resistance exercise; jumping, jarring, head-down activities; 
and breath holding should be avoided in anyone with severe 
non-proliferative and unstable proliferative diabetic retin-
opathy” [15]. Notably, our observation suggests that these 
recommendations are well grounded. It has been shown 
that autoregulation is disturbed in patients with diabetes 
and especially if the patient has poor glycaemic control and 
microvascular impairment [16]. In such patients, intensive 
exercise and the increase in blood pressure may lead to reti-
nal damage due to even further impaired autoregulation. On 
the other hand, further studies are needed to assess whether 
physical activity and potential hemodynamic adaptations 
Table 4  Cox regression models showing hazard ratios (HRs) regarding severe diabetic retinopathy for low and moderate versus high total LTPA, 
intensity, frequency and duration
LTPA leisure-time physical activity; SBP systolic blood pressure; TG triglycerides
LTPA Intensity Frequency Duration
Model 1: low, moderate, 
high
1.31 (0.91–1.89) 1.10 
(0.78–1.55) 1.00, 
N = 1612
0.92 (0.64–1.33) 0.92 
(0.69–1.23) 1.00, 
N = 1576
1.40 (1.03–1.89) 1.24 
(0.93–1.66) 1.00, 
N = 1595
0.94 (0.62–1.43) 0.92 
(0.70–1.21) 1.00, 
N = 1498
Model 2: Model 1 + gen-
der, duration of diabetes, 
age at onset of diabetes, 
kidney function
1.32 (0.91–1.90) 1.12 
(0.80–1.59) 1.00, 
N = 1609
1.01 (0.69–1.47) 1.02 
(0.75–1.38) 1.00, 
N = 1573
1.41 (1.04–1.92) 1.21 
(0.90–1.62) 1.00, 
N = 1592
0.97 (0.64–1.48) 0.98 
(0.74–1.30) 1.00, 
N = 1495
Model 3: Model 2 +SBP, 
TG, BMI,  HbA1c
1.27 (0.88–1.85) 1.34 
(0.94–1.91) 1.00, 
N = 1565
0.93 (0.63–1.38) 1.03 
(0.76–1.41) 1.00, 
N = 1529
1.25 (0.91–1.71) 1.21 
(0.90–1.63) 1.00, 
N = 1548
1.00 (0.65–1.54) 1.12 
(0.83–1.47) 1.00, 
N = 1452
Model 4: Model 3 + history 
of smoking
1.22 (0.83–1.77) 1.32 
(0.92–1.88) 1.00, 
N = 1518
0.82 (0.56–1.23) 0.98 
(0.72–1.34) 1.00, 
N = 1482
1.18 (0.85–1.62) 1.21 
(0.90–1.63) 1.00, 
N = 1502
0.96 (0.62–1.48) 1.08 
(0.81–1.44) 1.00, 
N = 1408
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could lead to improved vascular reactivity [17]. The finding 
regarding the potential benefit of frequent physical activity 
is also in line with the current ADA recommendations for 
physical activity in individuals with type 1 diabetes [15]. We 
cannot totally exclude any relationship between the other 
components of LTPA given the rather crude dichotomous 
classification of severe diabetic retinopathy (yes/no), which 
may reduce our possibility to demonstrate possible asso-
ciations. The use of the EDTRS scale, as well as thorough 
characterization of the retinal status by optical coherence 
tomography (OCT), could possibly help to identify those 
individuals that might benefit and those that might be at risk 
of further damage by physical activity.
In type 1 diabetes, glycaemic control, blood pressure and 
triglycerides are treatable or dynamic risk factors for dia-
betic retinopathy as shown in randomized controlled trials 
[18–22]. There is some evidence that smoking and obesity 
might also be treatable risk factors for diabetic retinopa-
thy [23–26]. Therefore, it is of note that there are several 
potential mechanisms, related to these factors, how physical 
activity might be beneficial for the prevention of diabetic 
retinopathy. In our multivariable analysis, the adjustment 
for  HbA1c abolished the association with frequent physical 
activity. This might be due to a beneficial effect of physical 
activity on  HbA1c. Furthermore, physical activity has been 
shown to improve insulin sensitivity in type 1 diabetes, but 
the evidence regarding  HbA1c lowering is so far controver-
sial [27]. This might be because  HbA1c may not be an ideal 
indicator of glycaemic control, since it does not reflect the 
glycaemic variability. Physical activity in general improves 
the lipid profile, BMI and blood pressure. However, in type 1 
diabetes only the improvement in lipid levels has been estab-
lished [28]. Since these dynamic factors did not mitigate the 
association of frequent physical activity with severe diabetic 
retinopathy in the multivariable analysis, the data suggest 
that a possible beneficial effect might be mediated through 
other factors. For example, it is well known that physical 
activity improves vascular endothelial function and reduces 
inflammation [28, 29].
An important strength of our study is the prospective 
study design including a large nationwide cohort of individ-
uals with type 1 diabetes. In addition, due to the nationwide 
registries there were no patients lost to follow-up. Given 
the size and the comprehensive nationwide approach, our 
study adds important information to the limited availability 
of data on physical activity and diabetic retinopathy in type 1 
diabetes. Importantly, we used a previously validated LTPA 
questionnaire capturing data not only on total LTPA but also 
on the various LTPA components, intensity, duration and 
frequency.
However, there are also some limitations. Physical 
activity was assessed by a self-report questionnaire, and 
work-related physical activity was not evaluated, a fact 
that could lead to a potential over- or underestimation of 
the true physical activity level. In addition, we could not 
assess the specific type of exercise (such as isotonic vs. 
isometric) that theoretically could affect the pathogenesis 
of diabetic retinopathy. More precise objective physical 
activity assessment tools are not feasible for such large 
nationwide cohorts as ours, and they have their own poten-
tial bias such as increased activity during surveillance. 
Some potential confounders such as nutrition and socio-
economic status were not either evaluated in our study. 
Instead, we used smoking as a confounder as smoking has 
been shown to be strongly correlated with the socio-eco-
nomic status [30, 31]. The development of severe diabetic 
retinopathy was assessed by information on laser treatment 
obtained from care registers rather than from a review of 
fundus photographs. Fundus photography would of course 
have given a more precise assessment of the disease status, 
and this limitation might have resulted in potential disease 
misclassification both at baseline and at follow-up. How-
ever, if anything, this crude classification may only have 
diluted the findings.
In conclusion, frequent LTPA was associated with a 
lower incidence of severe diabetic retinopathy in type 1 
diabetes during the follow-up. The total amount of LTPA 
or its components (intensity or the duration of a single ses-
sion) were not associated with severe diabetic retinopathy.
Acknowledgements Open access funding provided by University of 
Helsinki including Helsinki University Central Hospital. We acknowl-
edge the important role of all the FinnDiane physicians and nurses at 
each participating centre for the recruitment of patients and collection 
of samples and data (ESM Table 2). We are also indebted to our skilled 
nurses and technicians Maikki Parkkonen, Anna Sandelin, Jaana Tuo-
mikangas, Mira Korolainen and Hanna Olanne.
Author contributions CF, JW, LMT, MS, NE, HT and P-HG were 
involved in data collection; HT-D and VH analysed the data; and 
HT-D and P-HG wrote the manuscript. All authors contributed to and 
approved the final submitted version of the manuscript. P-HG takes 
full responsibility for the work as a whole, including the study design, 
access to the data and the decision to submit and publish the manu-
script. P-HG is the guarantor of this work and, as such, had full access 
to all the data in the study and takes responsibility for the integrity of 
the data and the accuracy of the data analysis.
Funding The FinnDiane Study Group was supported by grants 
from Folkhälsan Research Foundation, Wilhelm and Else Stock-
mann Foundation, Liv och Hälsa Society, Helsinki University Hos-
pital Research Funds, Academy of Finland, Novo Nordisk Founda-
tion (NNF14SA0003), Finska Läkaresällskapet and Tekes. HT-D 
was supported by grants from Diabetes Research Foundation, Juho 
Vainio Foundation and Aarne Koskelo Foundation. None of these bod-
ies played any role in data collection, analysis or preparation of the 
manuscript.
533Acta Diabetologica (2020) 57:527–534 
1 3
Compliance with ethical standards 
Conflict of interest P-H.G. has received investigator-initiated research 
grants from Eli Lilly and Roche; is an advisory board member for 
Abbvie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Med-
scape, MSD, Novartis, Novo Nordisk and Sanofi; and has received 
lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo 
Water, Genzyme, Medscape, MSD, Novartis, Novo Nordisk and Sa-
nofi. No other potential conflicts of interest relevant to this article were 
reported.
Ethical approval The study protocol was approved by the Ethical Com-
mittee of the Helsinki and Uusimaa Hospital District as well as by 
the local ethics committees at the participating centres and conducted 
according to the Declaration of Helsinki.
Human and animal rights disclosure The study protocol was approved 
by the Ethical Committee of the Helsinki and Uusimaa Hospital Dis-
trict as well as by the local ethics committees at the participating cen-
tres and conducted according to the Declaration of Helsinki.
Informed consent Before participation, all patients gave their written 
informed consent.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Dorman J, Laporte R, Kuller L et al (1984) Pittsburgh insulin-
dependent diabetes mellitus morbidity and mortality study: physi-
cal activity and diabetic complications. Diabetes 33:271–276
 2. Tielemans S, Soedamah-Muthu S, De Neve M et al (2013) Asso-
ciation of physical activity with all-cause mortality and incident 
and prevalent cardiovascular disease among patients with type 1 
diabetes: the EURODIAB prospective complications study. Dia-
betologia 56:82–91
 3. Tikkanen-Dolenc H, Wadén J, Forsblom C et al (2017) Frequent 
and intensive physical activity reduces risk of cardiovascular 
events in type 1 diabetes. Diabetologia 60:574–580
 4. Tikkanen-Dolenc WJ, Forsblom C et al (2017) Physical activity 
reduces risk of premature mortality in patients with type 1 diabe-
tes with and without kidney disease. Diabetes Care 40:1727–1732
 5. LaPorte RE, Dorman JS, Tajima N et al (1986) Insulin-dependent 
diabetes mellitus morbidity and mortality study: physical activity 
and diabetic complications. Pediatrics 78:1027–1033
 6. Kriska AM, LaPorte RE, Patrick SL et al (1991) The association 
of physical activity and diabetic complications in individuals with 
insulin-dependent diabetes mellitus: the epidemiology of diabetes 
complications study-VII. J Clin Epidemiol 44:1207–1214
 7. Cruickshanks KJ, Moss SE, Klein R, Klein BE (1992) Physical 
activity and proliferative retinopathy in people diagnosed with 
diabetes before age 30 years. Diabetes Care 15:1267–1272
 8. Wadén J, Tikkanen HK, Forsblom C et al (2015) Leisure-time 
physical activity and development and progression of diabetic 
nephropathy in type 1 diabetes: the FinnDiane study. Diabetologia 
58:929–936
 9. Wadén J, Forsblom C, Thorn LM et al (2008) Physical activity 
and diabetes complications in patients with type 1 diabetes: the 
Finnish diabetic nephropathy (FinnDiane) study. Diabetes Care 
31:230–232
 10. Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syn-
drome in type 1 diabetes: association with diabetic nephropathy 
and glycaemic control (the FinnDiane study). Diabetes Care 
28:2019–2024
 11. Levey AS, Stevens LA, Schmid CH (2009) A new equation to 
estimate glomerular filtration rate. Ann Int Med 150:604–612
 12. Slinde F, Arvidsson D, Sjoberg A et al (2003) Minnesota leisure 
time activity questionnaire and doubly labeled water in adoles-
cents. Med Sci Sports Exerc 35:1923–1928
 13. Lakka T, Salonen J (1992) Intra-person variability of various 
physical activity assessments in the Kuopio ischaemic heart dis-
ease risk factor study. Int J Epidemiol 21:467–472
 14. Salonen J, Lakka T (1987) Assessment of physical activity in 
population studies: validity and consistency of the methods in the 
Kuopio ischemic heart disease risk factor study. Scand J Sports 
Sci 9:89–95
 15. Colberg SR, Sigal RJ, Yardley JE et al (2016) Physical activity/
exercise and diabetes: a position statement of the American Dia-
betes Association. Diabetes Care 39:2065–2079
 16. Kohner EM et al (1995) Role of blood flow and impaired autoreg-
ulation in the pathogenesis of diabetic retinopathy. Diabetes 
44(6):603–607
 17. Nussbaumer M et al (2014) Effects of acute bouts of endurance 
exercise on retinal vessel diameters are age and intensity depend-
ent. Age 36(3):965
 18. U. K. Prospective Diabetes Study Group et al (1998) Intensive 
blood-glucose control with sulphonylureas or insulin compared 
with conventional treatment and risk of complications in patients 
with type 2 diabetes (UKPDS 33). Lancet 352.9131:837–853
 19. DCCT Group et al (2000) Retinopathy and nephropathy in patients 
with type 1 diabetes 4 years after a trial of intensive therapy. The 
Diabetes Control and Complications Trial/Epidemiology of Dia-
betes Interventions and Complications Research Group. N Engl J 
Med 342:381–389
 20. Chew EY, Ambrosius WT, Davis MD et al (2010) Effects of medi-
cal therapies on retinopathy progression in type 2 diabetes. N Engl 
J Med 363:233–244
 21. Matthews DR, Stratton IM, Aldington SJ et al (2004) Risks of 
progression of retinopathy and vision loss related to tight blood 
pressure control in type 2 diabetes mellitus: UKPDS 69. Arch 
Ophthalmol 122:1631–1640
 22. Keech AC, Mitchell P, Summanen PA et  al (2007) Effect of 
fenofibrate on the need for laser treatment for diabetic retin-
opathy (FIELD study): a randomised controlled trial. Lancet 
370.9600:1687–1697
 23. Porta M, Sjoelie AK, Chaturvedi N et  al (2001) Risk fac-
tors for progression to proliferative diabetic retinopathy in the 
EURODIAB prospective complications study. Diabetologia 
44:2203–2209
 24. Moss SE, Klein R, Klein BE (1991) Association of cigarette 
smoking with diabetic retinopathy. Diabetes Care 14:119–126
 25. Chaturvedi N, Stephenson JM, Fuller JH (1995) The relationship 
between smoking and microvascular complications in the EURO-
DIAB IDDM complications study. Diabetes Care 18:785–792
 26. Mühlhauser I, Bender R, Bott U et al (1996) Cigarette smoking 
and progression of retinopathy and nephropathy in type 1 diabetes. 
Diabet Med 13:536–543
 27. Kennedy A, Nirantharakumar K, Chimen M et al (2013) Does 
exercise improve glycaemic control in type 1 diabetes? A system-
atic review and meta-analysis. PloS one 8:e58861
 28. Chimen M, Kennedy A, Nirantharakumar K et al (2012) What are 
the health benefits of physical activity in type 1 diabetes mellitus? 
A literature review. Diabetologia 55:542–551
534 Acta Diabetologica (2020) 57:527–534
1 3
 29. Di Francescomarino S, Sciartilli A, Di Valerio V et al (2009) The 
effect of physical exercise on endothelial function. Sports Med 
39:797–812
 30. Hiscock et al (2012) Socioeconomic status and smoking: a review. 
Ann N Y Acad Sci 1248:107–123
 31. Laaksonen M et al (2005) Socioeconomic status and smoking: 
analysing inequalities with multiple indicators. Eur J Public 
Health 15:262–269
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
